G. Alex Bishop

Spontaneous acceptance of liver transplants in rodents: evidence that liver leucocytes induce recipient T-cell death by neglect.

Expression of growth arrest-specific gene 6 and its receptors in a rat model of chronic renal transplant rejection.

Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.

Postoperative administration of donor B cells induces rat kidney allograft acceptance: lack of association with Th2 cytokine expression in long-term accepted grafts.

A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.

Immune mechanisms contributing to spontaneous acceptance of liver transplants in rodents and their potential for clinical transplantation.

Expression of growth arrest-specific gene 6 and its receptors in dysfunctional human renal allografts.

A short course of mycophenolate immunosuppression inhibits rejection, but not tolerance, of rat liver allografts in association with inhibition of interleukin-4 and alloantibody responses.

Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejection.

Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.

Posttransplant interleukin-4 treatment converts rat liver allograft tolerance to rejection.

Simultaneous vascularized bone marrow transplantation to promote acceptance of hind limb allografts and its effects on central and peripheral chimerism.

The liver: a special case in transplantation tolerance.

Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: effect on foxp3 and cytokine expression and graft infiltration.

Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection.

Screening liver transplant patients for tolerance.

Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection.

Role of IL-4 and Th2 responses in allograft rejection and tolerance.

Gene therapy in transplantation.

Donor IL-4-treatment induces alternatively activated liver macrophages and IDO-expressing NK cells and promotes rat liver allograft acceptance.

Spontaneous acceptance of mouse kidney allografts is associated with increased Foxp3 expression and differences in the B and T cell compartments.

Approaching the promise of operational tolerance in clinical transplantation.

Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match.

Expression of common gamma chain signalling cytokines and their receptors distinguishes rejection from tolerance in a rat organ transplant model.

Intragraft Vδ1 γδ T cells with a unique T-cell receptor are closely associated with pediatric semiallogeneic liver transplant tolerance.

Gene therapy for tolerance: high-level expression of donor major histocompatibility complex in the liver overcomes naive and memory alloresponses to skin grafts.

Differential migration of passenger leukocytes and rapid deletion of naive alloreactive CD8 T cells after mouse liver transplantation.

Liver transplant tolerance and its application to the clinic: can we exploit the high dose effect?

Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4(+)CD25(+) T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients.

Antigen expression level threshold tunes the fate of CD8 T cells during primary hepatic immune responses.